ArticleCase reports in infectious diseases2026
Disseminated Herpes Simplex Virus Infection Presenting With Cytopenias in a Patient With Untreated Rheumatoid Arthritis.
Article in Case reports in infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Disseminated herpes simplex virus (HSV) infection is an uncommon but serious condition, typically seen in immunocompromised hosts. Cytopenias, including neutropenia and thrombocytopenia, are rare manifestations, particularly in patients not actively receiving immunosuppressive therapy. Case Presentation: We report a 75-year-old female with a history of rheumatoid arthritis (RA), previously on methotrexate and low-dose prednisone, who presented with painful oral and genital ulcers, mucositis, and rapidly progressive bicytopenia (neutropenia and thrombocytopenia). Her recent brief reinitiation of methotrexate prompted evaluation for drug-induced cytopenias; however, methotrexate levels were undetectable. Extensive infectious, nutritional, rheumatologic, and hematologic workup revealed HSV positivity from oral and inguinal ulcers. Bone marrow biopsy showed no evidence of hematologic malignancy or aplasia. She was treated with intravenous acyclovir, leading to clinical improvement and recovery of blood counts. Discussion: This case highlights the diagnostic complexity of cytopenias in patients with autoimmune diseases. While methotrexate toxicity and Felty's syndrome were initially considered, the clinical trajectory and lack of supportive findings redirected focus to infectious causes. Disseminated HSV infection causing cytopenias is rare and often overlooked in immunocompetent or intermittently immunosuppressed patients. In this patient, immune dysregulation due to underlying RA and advanced age likely contributed to HSV dissemination and bone marrow suppression. Conclusion: Clinicians should maintain a high index of suspicion for disseminated HSV in patients with autoimmune diseases presenting with mucocutaneous lesions and cytopenias, even in the absence of significant immunosuppressive therapy. Prompt recognition and antiviral therapy are critical to prevent complications and improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.